Cyient DLM Limited — Investor Meet, 27-01-2025: Analysts/Institutional Investor Meet/Con. Call Updates

1. **Financial Performance**: Cyient DLM reported a revenue of ₹444.2 crore, reflecting a 38.4% year-over-year growth, boosted by the acquisition of Altek Electronics. Standalone revenue reached ₹357.3 crore, marking an 11.3% increase. Adjusted EBITDA stood at ₹359 million, with an 8.1% margin, slightly down year-on-year due to one-off expenses associated with the acquisition. Reported PAT was ₹166 million, representing a 10% decline year-over-year.

2. **Future Outlook and Growth Drivers**: Management emphasized growth opportunities linked to localization trends in the U.S. and the integration of Altek, with expectations of synergy revenue materializing in upcoming quarters. The medical and industrial sectors are set to drive future growth, supported by ongoing recovery in these domains.

3. **Order Book and Operational Updates**: The order backlog has expanded to ₹2,142.9 crore, including ₹291.5 crore from Altek. Despite some organic decline, management noted the robust pipeline valued at over $1 billion, highlighting multiple large contract negotiations nearing conclusion.

4. **Analyst Q&A Insights (Detailed)**:

- **Revenue and Profitability**: Analysts expressed concerns about slower order wins, with management confirming an active pipeline and the expectation of converting several deals shortly.

- **Market Position and Competitive Landscape**: Management reaffirmed their competitive positioning, particularly gaining from U.S. defense contracts due to Altek’s capabilities.

- **Operational Challenges or Risks**: Analysts sought clarity on ECL provisions, which management described as a one-off event, indicating confidence in future collections.

- **Capex and Capital Allocation**: Inquiry regarding capex led to assurance from management that excess capacity exists, with only incremental investments planned moving forward.

- **Strategic Priorities and Long-Term Vision**: There was a clear indication from management that achieving a sustainable margin of 10% is a key target in the medium term, aligning with growth in both industrial and medical sectors.

5. **Market or Regulatory Updates**: The call highlighted increased demand for local manufacturing in the U.S. due to political changes favoring domestic production, potentially benefiting Cyient DLM through Altek's capabilities.

6. **Strategic Focus Areas**: Cyient DLM’s strategic emphasis is on integrating Altek effectively to exploit synergies in high-value, low-volume sectors, while also ramping up operational efficiencies across their divisions.

7. **Investor Insight**: The robust pipeline, solid financial health, and favorable industry trends position the company for continued growth, supporting a ‘buy’ stance based on potential for value appreciation and strategic expansion in key markets.